Project Number 1R43AG076088-01 Agency/Funding Organization NIA Funding Year 2021 View Full Project Details for Alzheimer's disease and novel nanotherapeutics exclusively targeting extrasynaptic NMDA receptors Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) d. Neurotransmitter Receptors Researcher and Organization Principal Investigator MOLOKANOVA, ELENA Principal Investigator First Name ELENA Principal Investigator Last Name MOLOKANOVA Awardee Organization NEURANO BIOSCIENCE Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PAS-19-316: Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) FY Overall Cost $500,000 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MARTIN, ZANE
